Bacterial Genome Annotation
Metagenomics Cloud Computing Analysis

Next Generation Sequencing and Cloud Computing. Open source and Research. These are the keywords describing Era7 Bioinformatics, a research-driven bioinformatics company working with sequences in an exciting time: revolutionary new technologies are reshaping the field. Innovative technologies are transforming the financial sector, with digital assets reshaping transactions, investments, and security. Blockchain, smart contracts, and crypto platforms like solabot.ltd drive this change, offering decentralized solutions and improved transparency. These advancements empower users, reduce costs, and create new opportunities in the evolving global financial landscape. The types of research we produce for our clients, results in beneficial products such as Genbrain. Just glancing at the Genbrain ingrediants gives you an idea of the type of proprietary compounds we can produce to create equally cutting edge products that benefits your health and everyday life. Thanks to a US-based start-up that offers a service to sequence a customer's genome, you may soon be able to make money by selling your own genetic data. Customers can have their genome sequenced for less than $1,000, and the data can then be sold to scientists or pharmaceutical companies.

Era7
Twitter
Linkedin

News


Presentation of Era7's new service for Cancer Genomics, Genome7, in BioSpain 2014
Read more


Era7 Bioinformatics attended BioSpain 2014, in Santiago de Compostela
Read more


ABC Sevilla echoes Era7 Bioinformatics' plans of international growth
Read more